Current molecular studies have furnished several insights into the procedures that govern the event and development of CLL, which includes a lot of novel mutated genes clustered in different practical pathways. The CLL epigenome is reprogrammed with the modulation of regulatory locations that appear de novoAre BTK and PLCG2 mutations important and